The PE Ratio as of October 2024 (TTM) for Virios Therapeutics, Inc. (VIRI) is -0.03

According to Virios Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -99.95% compared to the average of -59.11 of the last 4 quarters.

Virios Therapeutics, Inc. (VIRI) Historical PE Ratio (quarterly & annually)

How has VIRI PE Ratio performed in the past?

The mean historical PE Ratio of Virios Therapeutics, Inc. over the last ten years is -413.10. The current -0.03 PE Ratio has changed -99.27% with respect to the historical average. Over the past ten years (40 quarters), VIRI's PE Ratio was at its highest in in the September 2022 quarter at -8.60. The PE Ratio was at its lowest in in the March 2020 quarter at -1081.75.

Virios Therapeutics, Inc. (VIRI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Virios Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Virios Therapeutics, Inc. (VIRI) Average PE Ratio

How has VIRI PE Ratio performed in the past?

The current PE Ratio of Virios Therapeutics, Inc. (VIRI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Virios Therapeutics, Inc. (VIRI) PE Ratio vs. Peers

How is VIRI’s PE Ratio compared to its peers?

Virios Therapeutics, Inc.’s PE Ratio is greater than SeaStar Medical Holding Corporation (-0.29), greater than ZyVersa Therapeutics, Inc. (-0.07), greater than Sonnet BioTherapeutics Holdings, Inc. (-2.73), greater than Revelation Biosciences, Inc. (-0.08), less than eFFECTOR Therapeutics, Inc. (-0.00), greater than Zura Bio Limited (-10.89), less than Navidea Biopharmaceuticals, Inc. (0.03), greater than Immix Biopharma, Inc. (-2.41), less than CNS Pharmaceuticals, Inc. (-0.00), less than Altamira Therapeutics Ltd. (-0.03), greater than Phio Pharmaceuticals Corp. (-0.18), greater than TransCode Therapeutics, Inc. (-0.19),

Build a custom stock screener for Virios Therapeutics, Inc. (VIRI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virios Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virios Therapeutics, Inc. (VIRI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virios Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.